Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Atrial Fibrillation
Interventions
DEVICE

Implantation of LAA closure device

Trial Locations (7)

96450

Medizinische Klinikum Coburg, Coburg

Unknown

Charité - Universitätsmedizin Berlin, Berlin

Kardiologie Universitätsklinikum Bonn, Bonn

CardioVascular Center Frankfurt, Frankfurt

Klinik für Innere Medizin Kardiologie Herzzentrum Leipzig GmbH, Leipzig

University Medical Center of Johannes Gutenberg-University Mainz, Mainz

NHS Trust (ICHNT) Hammersmith Hospital London, London

Sponsors
All Listed Sponsors
lead

Occlutech International AB

INDUSTRY